A Systematic Review and Meta-Analysis on Depression and Associated Factors among Adult HIV/AIDS-Positive Patients Attending ART Clinics of Ethiopia: 2021.

Q1 Psychology
Depression Research and Treatment Pub Date : 2021-10-20 eCollection Date: 2021-01-01 DOI:10.1155/2021/8545934
Bitew Tefera Zewudie, Shegaw Geze, Yibeltal Mesfin, Muche Argaw, Haimanot Abebe, Zebene Mekonnen, Shegaw Tesfa, Bogale Chekole, Betelhem Tadesse, Agere Aynalem, Tadele Lankrew
{"title":"A Systematic Review and Meta-Analysis on Depression and Associated Factors among Adult HIV/AIDS-Positive Patients Attending ART Clinics of Ethiopia: 2021.","authors":"Bitew Tefera Zewudie,&nbsp;Shegaw Geze,&nbsp;Yibeltal Mesfin,&nbsp;Muche Argaw,&nbsp;Haimanot Abebe,&nbsp;Zebene Mekonnen,&nbsp;Shegaw Tesfa,&nbsp;Bogale Chekole,&nbsp;Betelhem Tadesse,&nbsp;Agere Aynalem,&nbsp;Tadele Lankrew","doi":"10.1155/2021/8545934","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Depression is the most common mental health problem in people living with the human immune virus. It ranges from 11% to 63% in low- and middle-income countries. Depression was high in people living with HIV/AIDS in developing countries, especially in the Ethiopian context. Even though depression has negative consequences on HIV-positive patients, the care given for depression in resource-limited countries like Ethiopia is below the standard in their HIV care programs.</p><p><strong>Method: </strong>International databases (Google Scholar, PubMed, Hinari, Embase, and Scopus) and Ethiopian university repository online have been covered in this review. Data were extracted using Microsoft Excel and analyzed by using the Stata version 14 software program. We detected the heterogeneity between studies using the <i>I</i> <sup>2</sup> test. We checked publication bias using a funnel plot test.</p><p><strong>Results: </strong>The overall pooled depression prevalence among adult HIV/AIDS patients attending antiretroviral therapy in Ethiopia was 36.3% (95% CI: 28.4%, 44.2%) based on the random effect analysis. Adult HIV/AIDS patients having CD4count < 200(AOR = 5.1; 95% CI: 2.89, 8.99), widowed marital status (AOR = 3.7; 95% CI: 2.394, 5.789), medication nonadherence (AOR = 2.3; 95% CI: 1.63, 3.15), poor social support (2.986) (95% CI: 2.139, 4.169), perceived social stigma (2.938) (2.305, 3.743), opportunistic infections (3.010) (2.182, 4.151), and adverse drug reactions (4.013) (1.971, 8.167) were significantly associated with depression among adult HIV/AIDS patients on antiretroviral therapy, in Ethiopia. <i>Conclusion and Recommendation</i>. The pooled depression prevalence among adult HIV/AIDS patients attending antiretroviral therapy in Ethiopia was higher than the general population and is alarming for the government to take special consideration for HIV-positive patients. Depression assessment for all HIV-positive patients and integrating with mental health should be incorporated to ensure early detection, prevention, and treatment. Community-based and longitudinal study designs mainly focusing on the incidence and determinants of depression among adult HIV/AIDS patients should be done in the future.</p>","PeriodicalId":38441,"journal":{"name":"Depression Research and Treatment","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550854/pdf/","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Depression Research and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2021/8545934","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Psychology","Score":null,"Total":0}
引用次数: 4

Abstract

Introduction: Depression is the most common mental health problem in people living with the human immune virus. It ranges from 11% to 63% in low- and middle-income countries. Depression was high in people living with HIV/AIDS in developing countries, especially in the Ethiopian context. Even though depression has negative consequences on HIV-positive patients, the care given for depression in resource-limited countries like Ethiopia is below the standard in their HIV care programs.

Method: International databases (Google Scholar, PubMed, Hinari, Embase, and Scopus) and Ethiopian university repository online have been covered in this review. Data were extracted using Microsoft Excel and analyzed by using the Stata version 14 software program. We detected the heterogeneity between studies using the I 2 test. We checked publication bias using a funnel plot test.

Results: The overall pooled depression prevalence among adult HIV/AIDS patients attending antiretroviral therapy in Ethiopia was 36.3% (95% CI: 28.4%, 44.2%) based on the random effect analysis. Adult HIV/AIDS patients having CD4count < 200(AOR = 5.1; 95% CI: 2.89, 8.99), widowed marital status (AOR = 3.7; 95% CI: 2.394, 5.789), medication nonadherence (AOR = 2.3; 95% CI: 1.63, 3.15), poor social support (2.986) (95% CI: 2.139, 4.169), perceived social stigma (2.938) (2.305, 3.743), opportunistic infections (3.010) (2.182, 4.151), and adverse drug reactions (4.013) (1.971, 8.167) were significantly associated with depression among adult HIV/AIDS patients on antiretroviral therapy, in Ethiopia. Conclusion and Recommendation. The pooled depression prevalence among adult HIV/AIDS patients attending antiretroviral therapy in Ethiopia was higher than the general population and is alarming for the government to take special consideration for HIV-positive patients. Depression assessment for all HIV-positive patients and integrating with mental health should be incorporated to ensure early detection, prevention, and treatment. Community-based and longitudinal study designs mainly focusing on the incidence and determinants of depression among adult HIV/AIDS patients should be done in the future.

Abstract Image

Abstract Image

Abstract Image

埃塞俄比亚ART诊所成年HIV/ aids阳性患者抑郁及相关因素的系统评价和荟萃分析:2021。
抑郁症是人类免疫病毒感染者最常见的心理健康问题。在低收入和中等收入国家,这一比例从11%到63%不等。在发展中国家,尤其是埃塞俄比亚,艾滋病毒/艾滋病感染者的抑郁程度很高。尽管抑郁症对艾滋病毒阳性患者有负面影响,但在埃塞俄比亚等资源有限的国家,对抑郁症的护理低于其艾滋病毒护理项目的标准。方法:本综述涵盖了国际数据库(Google Scholar、PubMed、Hinari、Embase和Scopus)和埃塞俄比亚大学在线数据库。使用Microsoft Excel提取数据,并使用Stata version 14软件程序进行分析。我们使用i2检验来检测研究之间的异质性。我们使用漏斗图检验来检验发表偏倚。结果:根据随机效应分析,在埃塞俄比亚接受抗逆转录病毒治疗的成年艾滋病毒/艾滋病患者中,总体合并抑郁症患病率为36.3% (95% CI: 28.4%, 44.2%)。cd4计数< 200的成人HIV/AIDS患者(AOR = 5.1;95% CI: 2.89, 8.99),丧偶婚姻状况(AOR = 3.7;95% CI: 2.394, 5.789),药物不依从(AOR = 2.3;95% CI: 1.63, 3.15)、社会支持差(2.986)(95% CI: 2.139, 4.169)、感知到的社会耻辱感(2.938)(2.305,3.743)、机会性感染(3.010)(2.182,4.151)和药物不良反应(4.013)(1.971,8.167)与埃塞俄比亚接受抗逆转录病毒治疗的成年艾滋病毒/艾滋病患者的抑郁显著相关。结论和建议。在埃塞俄比亚,接受抗逆转录病毒治疗的成年艾滋病毒/艾滋病患者中抑郁症的总体流行率高于一般人群,这给政府敲响了警钟,应特别考虑艾滋病毒阳性患者。应对所有艾滋病毒阳性患者进行抑郁评估,并将其与精神卫生相结合,以确保早期发现、预防和治疗。以社区为基础的和纵向的研究设计应该主要关注成年HIV/AIDS患者抑郁的发生率和决定因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Depression Research and Treatment
Depression Research and Treatment Psychology-Clinical Psychology
CiteScore
8.80
自引率
0.00%
发文量
8
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信